Friday, December 01, 2017 7:08:41 AM
The Kaya Cares program would see people interested in trying medical cannabis exchange their prescription opioids for cannabis products at no charge.
David Jones, Kaya senior advisor, pointed out that there are 91 opioid-related deaths per day in the U.S., which not only devastates families but “disrupts our economy with reduced productivity and increased healthcare costs.”
“We believe a program like Kaya Cares and other initiatives to be undertaken by [Kaya] will help transition people away from dangerous opioids, making the government’s war on opioids a little more successful,” he said in a press release announcing the program.
Kaya CEO Craig Frank said the company came up with the idea when President Donald Trump announced “the war on the opioid epidemic.”
“We want to help people in the communities we serve, as well as demonstrate that cannabis companies can be part of the President’s solution to the crisis,” he said in a statement.
President Trump’s opioid commission – headed up by cannabis prohibitionist Gov. Chris Christie – released their interim report in March which does not mention using cannabis as an exit drug despite private and government research.
Recent KAYS News
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/15/2024 09:38:31 PM
- Investor Ideas Potcasts: Interview with Kaya Holdings (OTCQB: KAYS) on the Sacred Mushroom Center - Pioneers with Psilocybin and Advocates for Mental Health • InvestorsHub NewsWire • 11/28/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 10:25:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 01:30:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 08:15:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 11:48:09 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:15:57 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 12:44:25 PM
- Kaya Holdings, Inc.'s V.P. Bryan Arnold Among First Ten (10) State Licensed Psilocybin Facilitators in U.S.A. • InvestorsHub NewsWire • 05/24/2023 01:48:14 PM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM